Skip to content

Total debt at other companies

TEC
Bio-TechneTECH
$290.32M-31.4%
Bruker logo
BrukerBRKR
$1.67B-20.9%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$110.84M+16.3%
Revvity logo
RevvityRVTY
$3.94B+17.8%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$987.3M-28.4%
Illumina logo
IlluminaILMN

Other financials

Income statement

See full
Revenue$150.8M-2.6%
Gross profit$106.2M+0.7%
Operating income-$17.0M+56.7%
Net income-$13.5M+60.8%
EPS (diluted)-$0.10+64.3%

Balance sheet

See full
Cash & equivalents$490.3M+30.0%
Total equity$814.3M+15.2%
Total assets$1.0B+12.4%

Cash flow

See full
Operating cash flow$26.1M-24.0%
CapEx$1.6M-15.6%
Free cash flow$24.5M-24.4%

Valuation

See full
Market cap$4.41B+154%
Enterprise value$4B+199%
P/S6.9×+4.1×

Profitability

See full
Gross margin69.6%+1.2pp
Operating margin-6.1%-2.7pp
Net margin-3.5%-1.6pp
FCF margin19.1%

Returns & leverage

See full
Return on equity-3%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.9×+0.5×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $81.39M.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 10x Genomics, Inc.'s total debt?
10x Genomics, Inc. (TXG) reported total debt of $81.39M in Q1 2026.
How has 10x Genomics, Inc.'s total debt changed year-over-year?
10x Genomics, Inc.'s total debt increased by 1.6% year-over-year, from $80.07M to $81.39M.
What is the long-term trend for 10x Genomics, Inc.'s total debt?
Over 5 years (2020 to 2025), 10x Genomics, Inc.'s total debt has grown at a 6.0% compound annual growth rate (CAGR), from $62.98M to $84.36M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.